Celeris Therapeutics

Description: Celeris Therapeutics uses AI to degrade undruggable targets with its Celeris One platform, predicting biomolecular interactions & expanding chemical space.

Country: Austria

Based in: Graz

Founded: 2021

Funding Stage: Seed

Tags: ['Biotechnology', 'Information Technology', 'Life Science', 'Pharmaceutical']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.